These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 38957687)

  • 1. Culture-Free Whole Genome Sequencing of
    Vasanthaiah S; Verma R; Kumar A; Bandari AK; George J; Rastogi M; Manjunath GK; Sharma J; Kumar A; Subramani J; Chawla K; Pandey A
    Open Forum Infect Dis; 2024 Jul; 11(7):ofae320. PubMed ID: 38957687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of targeted next-generation sequencing and the Xpert MTB/RIF assay for detection of
    Zhang H; Dai X; Hu P; Tian L; Li C; Ding B; Yang X; He X
    Microbiol Spectr; 2024 May; 12(5):e0409823. PubMed ID: 38602399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating the clinical impact of routine whole genome sequencing in tuberculosis treatment decisions and the issue of isoniazid mono-resistance.
    Park M; Lalvani A; Satta G; Kon OM
    BMC Infect Dis; 2022 Apr; 22(1):349. PubMed ID: 35392842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy of whole genome sequencing versus phenotypic (MGIT) and commercial molecular tests for detection of drug-resistant Mycobacterium tuberculosis isolated from patients in Brazil and Mozambique.
    Feliciano CS; Namburete EI; Rodrigues Plaça J; Peronni K; Dippenaar A; Warren RM; Silva WA; Bollela VR
    Tuberculosis (Edinb); 2018 May; 110():59-67. PubMed ID: 29779775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of Minority Variants and Mixed Infections in Mycobacterium tuberculosis by Direct Whole-Genome Sequencing on Noncultured Specimens Using a Specific-DNA Capture Strategy.
    Lozano N; Lanza VF; Suárez-González J; Herranz M; Sola-Campoy PJ; Rodríguez-Grande C; Buenestado-Serrano S; Ruiz-Serrano MJ; Tudó G; Alcaide F; Muñoz P; García de Viedma D; Pérez-Lago L
    mSphere; 2021 Dec; 6(6):e0074421. PubMed ID: 34908457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of Xpert MTB/RIF results for the detection of Mycobacterium tuberculosis in clinical samples].
    Ciftçi IH; Aslan MH; Aşık G
    Mikrobiyol Bul; 2011 Jan; 45(1):43-7. PubMed ID: 21341158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole-genome sequencing of presumptive MDR-TB isolates from a tertiary healthcare setting in Mumbai.
    Zade A; Shah S; Hirani N; Kondabagil K; Joshi A; Chatterjee A
    J Glob Antimicrob Resist; 2022 Dec; 31():256-262. PubMed ID: 36272707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole-genome sequencing reveals genotypic resistance in phenotypically susceptible
    Hasan Z; Razzak SA; Kanji A; Shakoor S; Hasan R
    Int J Mycobacteriol; 2023; 12(2):179-183. PubMed ID: 37338481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Xpert MTB/RIF performance to diagnose tuberculosis and rifampicin resistance in a reference centre in southern Brazil.
    Feliciano CS; Menon LJB; Anselmo LMP; Dippenaar A; Warren RM; Silva WA; Bollela VR
    ERJ Open Res; 2019 Jul; 5(3):. PubMed ID: 31404338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The New Xpert MTB/RIF Ultra: Improving Detection of
    Chakravorty S; Simmons AM; Rowneki M; Parmar H; Cao Y; Ryan J; Banada PP; Deshpande S; Shenai S; Gall A; Glass J; Krieswirth B; Schumacher SG; Nabeta P; Tukvadze N; Rodrigues C; Skrahina A; Tagliani E; Cirillo DM; Davidow A; Denkinger CM; Persing D; Kwiatkowski R; Jones M; Alland D
    mBio; 2017 Aug; 8(4):. PubMed ID: 28851844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of GeneXpert
    Habous M; E Elimam MA; Kumar R; L Deesi ZA
    Int J Mycobacteriol; 2019; 8(2):132-137. PubMed ID: 31210154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Application of Gene Xpert Mycobacterium tuberculosis DNA and resistance to rifampicin assay in the rapid detection of tuberculosis in children].
    Zhang AM; Li F; Liu XH; Xia L; Lu SH
    Zhonghua Er Ke Za Zhi; 2016 May; 54(5):370-4. PubMed ID: 27143080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for HIV-associated tuberculosis and rifampicin resistance before antiretroviral therapy using the Xpert MTB/RIF assay: a prospective study.
    Lawn SD; Brooks SV; Kranzer K; Nicol MP; Whitelaw A; Vogt M; Bekker LG; Wood R
    PLoS Med; 2011 Jul; 8(7):e1001067. PubMed ID: 21818180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Xpert MTB/RIF with other nucleic acid technologies for diagnosing pulmonary tuberculosis in a high HIV prevalence setting: a prospective study.
    Scott LE; McCarthy K; Gous N; Nduna M; Van Rie A; Sanne I; Venter WF; Duse A; Stevens W
    PLoS Med; 2011 Jul; 8(7):e1001061. PubMed ID: 21814495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting.
    Theron G; Peter J; van Zyl-Smit R; Mishra H; Streicher E; Murray S; Dawson R; Whitelaw A; Hoelscher M; Sharma S; Pai M; Warren R; Dheda K
    Am J Respir Crit Care Med; 2011 Jul; 184(1):132-40. PubMed ID: 21493734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid identification of a Mycobacterium tuberculosis full genetic drug resistance profile through whole genome sequencing directly from sputum.
    Nimmo C; Doyle R; Burgess C; Williams R; Gorton R; McHugh TD; Brown M; Morris-Jones S; Booth H; Breuer J
    Int J Infect Dis; 2017 Sep; 62():44-46. PubMed ID: 28716462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary and extrapulmonary tuberculosis in an intermediate-prevalence setting].
    Ozkutuk N; Surucüoglu S
    Mikrobiyol Bul; 2014 Apr; 48(2):223-32. PubMed ID: 24819260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Best approaches to drug-resistance surveillance at the country level.
    Cabibbe AM; Cirillo DM
    Int J Mycobacteriol; 2016 Dec; 5 Suppl 1():S40-S41. PubMed ID: 28043601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Xpert MTB/RIF for rapid detection of rifampicin-resistant Mycobacterium tuberculosis from pulmonary tuberculosis patients in Southwest Ethiopia.
    Tadesse M; Aragaw D; Dimah B; Efa F; Abebe G
    Int J Mycobacteriol; 2016 Dec; 5 Suppl 1():S48-S49. PubMed ID: 28043605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genotypic drug resistance using whole-genome sequencing of Mycobacterium tuberculosis clinical isolates from North-western Tanzania.
    Kidenya BR; Mshana SE; Fitzgerald DW; Ocheretina O
    Tuberculosis (Edinb); 2018 Mar; 109():97-101. PubMed ID: 29559127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.